1 of the 3 cortisol metabolites. Active form.
a-THF
Anaplasma phagocytophilum Ab (IgG) testing is a serological method used to detect antibodies, specifically Immunoglobulin G (IgG), against Anaplasma phagocytophilum, the bacterium responsible for the tick-borne disease known as anaplasmosis. The presence of IgG antibodies typically indicates past exposure or a more chronic immune response to this pathogen. IgG antibodies against A. phagocytophilum usually develop a few weeks after the initial infection and can persist in the bloodstream for a prolonged period, making them useful markers for past infection. This test is particularly valuable in diagnosing patients with a history of tick exposure who present with symptoms consistent with anaplasmosis, such as fever, headache, muscle pain, and sometimes more severe manifestations like thrombocytopenia and leukopenia. A positive IgG test result suggests that the patient has been exposed to A. phagocytophilum, but it's important to note that it does not necessarily indicate an active infection, as IgG antibodies can remain long after the initial exposure has resolved. For this reason, the interpretation of A. phagocytophilum IgG results should be done in conjunction with a thorough evaluation of the patient's clinical history, symptomatology, and other laboratory findings. In some cases, additional testing, such as polymerase chain reaction (PCR) or testing for IgM antibodies, which are produced earlier in the infection, may be necessary to confirm a current infection. Clinicians often use the results of the A. phagocytophilum Ab (IgG) test in combination with other diagnostic information to accurately diagnose and manage cases of anaplasmosis.
for detecting acute infections caused by Anaplasma phagocytophilum
Genes associated with clarithromycin resistance
Genes associated with clarithromycin resistance
Genes associated with clarithromycin resistance
Genes associated with tetracycline resistance
The AA (Arachidonic Acid) test in red blood cells (RBC), a critical component of the Micronutrient panel by Vibrant America, provides an essential analysis of arachidonic acid levels, a prominent omega-6 fatty acid. AA plays a significant role in inflammatory and immune responses and is a key component of cell membranes, impacting cellular signaling and function. Measuring AA in RBCs offers a more accurate and long-term view of the body's fatty acid profile than serum levels, reflecting true cellular uptake and utilization. This test is particularly crucial in evaluating the balance between omega-6 and omega-3 fatty acids, which is vital for maintaining optimal health and preventing chronic diseases. An imbalance, especially high AA levels, can be associated with inflammatory conditions, such as arthritis, cardiovascular diseases, and other chronic health issues. Vibrant America's Micronutrient panel, inclusive of the AA (RBC) test, is an invaluable tool for healthcare practitioners in diagnosing and managing conditions related to omega-6 fatty acids and in customizing nutrition and supplementation plans. It's particularly beneficial for individuals with diets high in animal fats or those experiencing symptoms of inflammation. Accurately monitoring AA levels is crucial in preventive healthcare, aiding in the early detection of potential health problems and contributing to the development of targeted therapeutic strategies for enhanced health and well-being.
Cardiovascular Risk
Cardiovascular Risk
The AA/EPA ratio is your level of arachidonic acid (AA), an omega-6 fatty acid, vs. eicosapentaenoic acid (EPA), an omega-3 fatty acid. These are important fatty acids in metabolism because eicosanoids and prostaglandins can be made from them. These molecules are very potent in the body in causing a lot of changes. Having different levels of these two fatty acids could affect processes that ultimately impact inflammation and overall health. We recommend optimizing the omega-3 side of the equation, which inevitably means increasing your Omega-3 Index and getting into the optimal range. Only one omega-6 fatty acid, arachidonic acid (AA), and one omega-3 fatty acid, eicosapentaenoic acid (EPA), make up the AA:EPA ratio. The desirable range for the AA:EPA ratio is 2.5:1 – 11:1. The desirable ranges for the ratio were calculated to correspond to the desirable range for the Omega-3 Index due to the strong relationship among these metrics. Higher omega-3 blood levels are strongly related to improved health and longevity. Please consult with your healthcare provider before making any dietary changes. The most efficient way to lower both the Omega-6:Omega-3 and the AA:EPA ratios is to consume more omega-3 EPA and DHA from fish or supplements. Omega-6 blood levels are less responsive to dietary changes than omega-3 blood levels. Therefore, lowering dietary omega-6s as a strategy to correct these ratios is typically less effective than raising intake of EPA and DHA. It will take 3-4 months for these ratios to reach their new levels and we recommend re-testing at that time.
The AA/EPA Ratio is one of the most common tests for cellular inflammation.
One of the most common tests for cellular inflammation
The AA/EPA Ratio is one of the most common tests for cellular inflammation.
One of the most common tests for cellular inflammation
One of the most common tests for cellular inflammation
One of the most common tests for cellular inflammation